Democracy, technocracy, and the secret state of medicines control: Expert and nonexpert perspectives

被引:31
作者
Abraham, J [1 ]
Sheppard, J [1 ]
机构
[1] GENET FORUM, LONDON EC2A 2BH, ENGLAND
关键词
D O I
10.1177/016224399702200201
中图分类号
D58 [社会生活与社会问题]; C913 [社会生活与社会问题];
学科分类号
摘要
This article explores the social frameworks guiding expert and nonexpert perspectives on medicines safety in the U.K. Scientific experts from the Committee on the Safety of Medicines and the Medicines Commission were interviewed, and three nonexpert groups, including patients and health professionals, were studied by the administration of questionnaires and focused group discussions. The research examined to what extent these groups subscribed to technocratic or democratic approaches to medicines regulation and how this might be related to values toward technological risk. The results reveal that there is substantial divergence between expert and nonexpert perspectives on medicines regulation, and that this derives as much from value differences as from any informational deficits. However there seems to be some scope for shared values between some experts and some nonexperts, especially as regards state secrecy: The article concludes by discussing how those values could be used to foster a new ''social contract of expertise'' in which scientists are more democratically accountable and patients take more responsibility in governing medical risks.
引用
收藏
页码:139 / 167
页数:29
相关论文
共 38 条
[1]  
Abraham J., 1995, SCI POLITICS PHARM I
[2]  
Albrecht Terrance L., 1993, Successful Focus Groups: Advancing the State of the Art, P51, DOI DOI 10.4135/9781483349008
[3]  
[Anonymous], ENV THREATS
[4]  
[Anonymous], SOC TECHNOLOGY RISK
[5]  
Beck Ulrich., 1992, Risk society: Towards a new modernity
[6]   THE CAUSES OF DISEASE - WOMEN TALKING [J].
BLAXTER, M .
SOCIAL SCIENCE & MEDICINE, 1983, 17 (02) :59-69
[7]  
Brickman Ronald., 1985, Controlling Chemicals: The Politics of Regulation in Europe and the United States
[8]  
Calnan M., 1987, HLTH ILLNESS LAY PER
[9]  
Dickson David., 1988, The New Politics of Science
[10]   THE CONSTRUCTION OF LAY EXPERTISE - AIDS ACTIVISM AND THE FORGING OF CREDIBILITY IN THE REFORM OF CLINICAL-TRIALS [J].
EPSTEIN, S .
SCIENCE TECHNOLOGY & HUMAN VALUES, 1995, 20 (04) :408-437